During the last decade, a sudden decline in human male fertility has become a global concern. Genetic, endocrine and life style related problems are generally considered to be the underlie causes. However, several cases have been reported where hormones fail to promote spermatogenesis. The reason of such reproductive malfunctioning leading to male infertility remains idiopathic. Therefore, a sincere attention with a coordinated multidisciplinary effort by the andrologists, urologists and basic scientists is needed to understand the regulation of the sperm production. Powerful tools like high through put gene expression analyses, genetically manipulated mouse models and tissue culture or transplantation based assays are now available, increasing the scope of a establishing a special line of therapy for idiopathic male infertility. In this review, we have briefly summarized various categories of male infertility with emphasis on current research advancement in this field.
INTRODUCTION
The alarming decline in sperm count with poor under stan ding about the mechanisms involved is a great challenge for the clinicians for delivering appropriate therapy. 1 Research in the last decade has revealed various aspects of male reproductive health of human, such as the rising incidence of primary testicular failure, testicular cancer, declining semen quality, increasing frequencies of undescended testis, hypospadias, precocious male puberty and ultimately male infertility. 2 Here, we have briefly discussed these various aspects of reproductive health of human and will highlight the probable cause and remedies.
Primary Testicular Failure
Testes are the major endocrine gland of the male repro ductive system. Endocrine testicular failure results in andro gen deficiency. In primary endocrine testicular failure, a decline in testosterone (T) secretion resul ting in a condition termed hypoandrogenism is caused by a deficiency or absence of Leydig cell (LC) function. However, the major phenotype of primary exocrine testi cular failure is male infertility. Clinically, relevant diseases described here are anorchia, LC hypoplasia, GC aplasia, spermatogenetic arrest, hypospermatogenesis and nume rical chromosomal abnormalities as well as Y chromosome microdeletions. 2 
Congenital Anorchia
Bilateral anorchia is defined as complete absence of testicular tissue in genetically and phenotypically male patients. Bilateral congenital anorchia is rare, the incidence appears to be 1:20,000 males. In unilateral anorchia, testicular tissue is still present on the contra lateral side. Unilateral congenital anorchia is about 4 times as frequent. In patients with congenital bilateral anorchia serum gona dotropins are already elevated in childhood and rise to very high levels from the age of puberty onwards. T levels remain within the castrate range. In patients with suspected bilateral anorchia, it is mandatory to rule out cryptorchidism, as cryptorchidism is associated with an increased risk for testicular cancer and should definitively not be overlooked. Both the hCG stimulation test, that examines T secretory capacity, and serum antiMüllerian hormone (AMH) measurement can be used for differential diagnosis. During hCG administration T levels remain unchanged in patients with bilateral anorchia even after a 7day period of stimulation while a rise can be detected in patients with cryptorchidism. In comparison to the hCG test, measurement of AMH, which is undetectable in anorchia, has a higher sensitivity, but equal specificity for differentiation of bilateral anorchia from bilateral cryptorchidism. Endocrine tests are not useful for differential diagnosis of unilateral anorchia. In these cases imaging techniques, such as computer tomography or MRT and finally exploratory surgery or laparoscopy have to be applied. Unilateral anorchia does not require therapy. In phenotypically male patients with bilateral congenital anorchia T substitution has to be implemented at the time of expected puberty. For psychological or cosmetic reasons implantation of testicular prostheses could be offered to the patient although these are often expensive. To date, there is no treat ment of infertility in bilateral anorchia. 2 
Leydig Cell Hyperplasia
Leydig cell hypoplasia is a rare disease with an auto somal recessive pattern of inheritance and estimated incidence of 1:1,000,000. Leydig cells are unable to develop because of inactivating mutations of the LHreceptor (LHR) that fails to provide the necessary stimulation of intracellular pathways. Men with LC hypoplasia present with very low serum T and high LH levels. The phenotype is dependent on the extent of intrauterine T secretion. Two types of LC hypoplasia have been described.
• Type I is the most severe form, resulting in a female pheno type of the external genitalia with blind ending vagina, primary amenorrhea, and absence of secon dary sex differentiation at puberty. It is caused by inactivating mutations in the LHR that completely prevent LH and hCG signal transduction and thus T production.
• Type II LC hypoplasia is characterized by milder signs of androgen deficiency with hypogonadism with micropenis and/or hypospadia. This milder form is derived from mutations of the LHR, which only partially inactivate signal transduction and retain some responsiveness to LH. Testicular histology reveals semi niferous tubules, whereas LC are not present or appear only as immature forms. Epididymides and deferent ducts are usually present, whereas the uterus, tubes or upper vagina are not found. 2 
Spermatogenic Failure
Whereas endocrine testicular failure causes hypo gona dism, spermatogenic failure-defined as exocrine testi cular failure-leads to male infertility. Spermatogenic failure might be caused by hypothalamic, pituitary, testicular or posttesticular disorders. Various testicular etiologies of spermatogenic failure may lead to the same histopathological pattern. In this sense, GC aplasia, spermatogenic arrest, and hypospermatogenesis have to be considered as a description of certain histopathologic phenotypes of spermatogenetic failure, and not as manifestations of single disease entities 2 (Table 1) . It is important to note that numerous mouse knock out models that display as spermatogenic phenotype, including sperm cell arrest, has contributed little of clinical relevance to the large number of men with idiopathic infertility. The possible role of several gene mutations and polymorphisms has been extensively investigated but no clear-cut genetic factor could be identified so far. An association between increased androgen receptor CAG repeat length (which reduces the transcriptional activity of the androgen receptor) and idiopathic male infertility is suggested by a recent, comprehensive meta-analysis. However, no gene mutation or polymorphism analysis has the necessary sensitivity and specificity to be recommended as a diagnostic tool in the workup of male infertility.
Numerical Chromosomal Abnormalities

Hypospermatogenesis
This is the final and major histological grouping in primary exocrine testicular failure in which all GC types, including mature spermatids, is present in some or all tubules, but are mildly, moderately or severely reduced in number. Some patients have the appearance of complete GC aplasia in some tubules but with complete spermatogenesis in adjacent tubules (sometimes called 'focal' germinal cell aplasia) while others have the appearance of an excess number of precursor GC in relation to the number of mature spermatids in the epithelium. In most patients with hypospermatogenesis testicular volume is reduced. FSH is elevated in most, but not all patients, with serum levels correlating positively with the proportion of tubules with GC aplasia. Several studies have demonstrated that inhibin B is a more sensitive and specific endocrine marker of hypospermatogenesis. However, even the combined measurement of inhibin B and FSH provides no certainty concerning the presence or absence of sperm in multiple testicular biopsies. In azoospermic men with severe hypospermatogenesis, pregnancies can be achieved with testicular sperm extracted (TESE) from testicular biopsies that are injected into mature oocytes by intracytoplasmic sperm injection (ICSI). It has been suggested that residual sperm production could be improved by FSH therapy in incomplete GC aplasia. However, randomized studies performed so far have demonstrated some increase in total sperm count in the ejaculate but failed to prove a significant effect on fertility.
region Y) from the Y to the X chromosome takes place during paternal meiosis. 
Y chromosome microdeletions:
The longarm of the Y chro mosome contains four partially overlapping but discrete regions that are essential for normal spermatogenesis. The loss of one of these regions, designated as AZF (azoospermia factor) a, P5/proximal P1 (AZFb), P5/distal P1 (AZFb) and AZFc (or b2/b4), can lead to infertility. The deleted regions are usually of submicroscopic dimensions and are known as Y chromosome microdeletions. Their prevalence in azoospermic men lies between 5 and 10% and between 2 and 5% in cases of severe oligozoospermia. Clinically, the patients present with severely disturbed spermatogenesis; endocrine testicular function may or may not be affected by the microdeletion as in other cases of spermatogenetic failure. Testicular histopathology varies from complete or focal Sertolicellonly pattern to spermatogenic arrest or hypospermatogenesis with qualitatively intact but quantitatively severely reduced spermatogenesis. In azoospermic men, the presence of a complete deletion of AZFa or AZFb seems to be associated with uniform GC aplasia and negative prognostic value for testicular sperm retrieval. No clinical parameter can help distinguishing patients with microdeletions of the Y chromosome from infertile men without microdeletion. It should be noted that Y chromosome microdeletions have also been described in proven fertile men. Table 2 describes the frequencies of all such patho physiological conditions leading to male infertility.
Testicular Dysgenesis Syndrome
Several lifestyle (obesity, smoking) and environmental related (exposure to traffic exhaust fumes, dioxins, combu stion products, pesticides, food additives, persis tent pollutants, such as DDT, polychlorinated biphenyls) factors have appeared to be negatively associated with both the perinatal and adult testes, emphasizing the importance of environmental/lifestyle impacts through out the life course. Such observations have recently 3 given rise to this testicular dysgenesis syndrome (TDS) hypothesis which proposes that each of these dis orders may have a common fetal origin triggered by mal development of the testis, leading to mal function testes. We will now summarize these new aspects of poor semen quality, testis cancer, undescended testis and hypo spadias are symptoms of one underlying entity, TDS, which is increasingly common due to adverse environ mental influences.
Testicular Germ Cell Cancer
Germ cell proliferate and differentiate normally during fetal life and in the postnatal period to facilitate normal spermato genesis in adulthood. However, GC diffe rentiation in peri natal life and the regulatory pro cesses involved are poorly understood. Based on rodent studies, there are three impor tant steps of this process (as discussed earlier in the text see Biology of Spermatogenesis section). At first, the fetal GC lose their pluripotency, by expressing a number of differentiating markers shared with embryonic stem cells (e.g. OCT4). Failure to execute this differentiation step results in persistence of pluripotency characteris tics, which is dangerous as such cells can potentially differen tiate into various tissues. Such a failure is thought to be the underlying mechanism via which carcinoma in situ (CIS) cells are formed in the human, and it is from these CIS cells that testicular germ cell cancer (TGCC) subsequently develops in young adulthood incidence of TGCC has increased progressively in many Western nations over the past 60 years, and among Caucasians is the commonest cancer of young men. This increase is too rapid to be explained by genetic factors and is, therefore, presumed to have environmental/lifestyle causes. This is reinforced by studies of migrants from a country with a high incidence of TGCC (e.g. Denmark) to a country with a lower incidence (e.g. Finland, Sweden). Risk of TGCC in migrant males is comparable to their country of origin, but incidence of risk in children born in the country to which their parents have emigrated is the same as in that country. The causes of the increase in TGCC and the betweencountry differences are unexplained, but dif ferential exposure to environmental chemicals (ECs) has been suggested as one of the possibilities. This includes (i) Danish men born during the Second World War had a lower frequency of testicular cancer in adulthood than expected from the overall incidence of the disease, and (ii) a strong association between lowbirth weight and testicular cancer.
Cryptorchidism and Hypospadias
Other disorders of male reproductive development, such as cryptorchidism (undescended testis) and hypospadias 
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(birth defect of urethra), are associated with increased risk of TGCC, and individuals with low sperm counts/ quality and, therefore, infertility in adulthood are also at increased risk of TGCC. Studies have showed that cryptorchoid testis is associated with some degree of maldevelopment of the seminiferous tubules followed by primary testicular failure (as we have discussed earlier in this section), including Sertolicellonly syndrome and spermatogenic arrest. Moreover, the association of cryptorchidism with testicular cancer is also well docu mented. Since, undescended testis is an usual phenom enon at the time of birth, the condition is, per definition, of fetal origin, which again is in line with reports showing a strong association between low birth weight and the tes ticular maldescent. Although the molecular mechanisms behind the recent rise in the incidence of cryptorchidism are not known, the influence of environmental factors is a plausible hypothesis.
Testicular Dysgenesis Syndrome and Environment
Testicular dysgenesis syndrome may be caused by genetic or environmental factors, or a combination of both. The advent of modern mole cular genetics has expanded the understanding of gene tics of endocrine disorders, including dysgenesis of the testis, which may be caused by a range of genetic defects. However, in a significant number, perhaps the majority, of newborns with malformations of genitalia, no chromosomal or other genetic defect can be demonstrated with our current knowledge. These cases should be subject to exploration for possible environmental etiology. The relevance of considering a possible role of environment factors for development of TDS is high lighted by epidemiological findings of geographic and temporal synchrony in the symptoms of TDS. As stated earlier, the rates of testis cancer, undescended testis and hypospadias are much lower in Finland than Denmark.
Effects of maternal lifestyle/environment on son's testes:
The incidence of female obesity has increased considerably, and one preliminary study has suggested that high maternal BMI negatively affects semen quality in resulting sons when they grow to adulthood, with indirect evidence pointing toward reduced SC number. Over the same time period, exposure to a wide range of environmental chemicals (ECs) has increased, several of which are clearly documented to have intrinsic endo crinedisrupting activity, in particular antiandrogenic activity. The socalled 'estrogen hypothesis' has been expanded to include also environmental antiandrogens as endocrine disrupters with potential adverse effect on male reproductive health. For example, (i) many of the persistent organochlorine compounds, including various pesticides and polychlorinated biphenyls (PCBs), are lipophilic and accumulate in fat. Exposure of a range of persistent ECs (e.g. PCBs, polybrominated compounds or certain phthalates) present in cosmetics/toiletries/ medications during pregnancy are known to increase the risk of TDS disorders human male offspring in adulthood.
(ii) Dioxin (2,3,7,8tetrachlorodibenzopdioxin) is a highly toxic byproduct of combustion interact with the aryl hydrocarbon (AH) receptor, and a number of other ECs also interact with this receptor, such as polycyclic aromatic hydrocarbons (PAHs) that are constituents of exhaust fumes, smoke and cooking processes. Human exposure during pregnancy to dioxin as a result of the Seveso accident in 1976 resulted in lower sperm counts in 'exposed' (fetal) males in adulthood whereas those who were exposed to dioxin as adult men showed no effect. (iii) Substantial reductions in sperm counts (approx. 40% in three studies) were found in men whose mothers had smoked heavily in pregnancy Whatever the explanation, the initial trigger will probably have involved interaction of PAHs (or other constituents) in the cigarette smoke with the Ah receptor, although other mechanisms are possible. A interesting finding from studies involving exposure of fetal rats to antiandrogenic chemicals during specific fetal time windows is that exposure during what is termed the 'masculinization programming window' is associated in adulthood with reduced testicular size and presumably therefore reduced sperm production, although the basis for this relationship has yet to be established as it does not appear to involve a straightforward relationship with SC number. It is important to note that, although all these human male reproductive problems currently of concern in relation to environmental hazards can be experimentally produced in rodents by pre and perinatal exposure to endocrine disrupters-with the exception of GC cancer, for which, unfortunately, there is no suitable animal model as yet.
Obesity
An important lifestyledependent factor that adversely affects spermatogenesis is obesity. Several studies have shownup to a threefold higher incidence of obesity in infertile men than in those with normal semen quality, a BMI of more than 25 is associated with an average 25% reduction in sperm count and sperm motility. Obesity in men is associated with reduced blood T levels, this reduction being proportional to the degree of obesity. Another explanation for reduced spermatogenesis in obese men could be deposition of fat around the scrotal blood vessels, leading to impaired blood cooling and elevated testicular temperature.
Smoking, Alcohol and Drugs
Smoking and alcohol consumption are two major lifestyle factors that have adverse effects on male reproductive health. The effects of recreational, sports (anabolic steroids) and therapeutic drugs on spermatogenesis in men are also reported. Administration of androgenic steroids to men results in reduced spermatogenesis because it causes suppression of LH secretion from the pituitary gland and a resulting suppression of intratesticular T levels; this has been widely evaluated as an approach to male contraception. Some chemotherapeutic agents (antimitotics, such as cyclophosphamide) used for treat ment of cancers or of some kidney diseases have well documented adverse effects on spermatogenesis and/or fertility. Studies indicate reduced fertility in epileptic men and one explanation is that the drugs used for treatment (carbamazepine, oxcarbazepine, valproate) are associated with adverse effects on sperm number, morphology or motility.
Scrotal Heating and Sedentary Position
Testicular descent into the scrotum normally occurs by birth in boys and failure of testicular descent (cryp torchidism), especially when this extends into puberty and adulthood, results in absence of spermatogenesis. The testes descend into the scrotum in order that their temperature can be kept 3 to 4°C below core body tem perature, as maintenance at normal body temperature is incompatible with spermatogenesis. Heat exposure causes hypoxia and oxidative stress responses in the GC, manifest as increased expression of hypoxia inducible factor 1α, hemoxygenase 1, glutathione peroxidase 1 and glutathioneStransferaseα, which induce GC apoptosis. Lifestyle and occupational factors that cause men to spend a long time in a sedentary position, something that has become common for many men working in today. For example, studies in lorry and taxi drivers, who spend a long time seated, have also produced evidence for detrimental effects on semen quality.
Environmental Exposure to Pollutants
Exposure to ozone as the result of general atmospheric pollution has been negatively associated with sperm counts in a large group of sperm donors. The environ mental pesticide exposures via fruit and vegetables or the general environment can adversely affect spermatogenesis in men at large. Exposure to organochlorine pesticides (e.g. DDT) that have been banned in western countries, as there will no longer be occupational exposure to such compounds, whereas there is exposure of the general population because of their persistence in the environment and food chain. There are one or two welldocumented examples of occupationally induced infertility resulting from EC exposure, the best known being that of dibromochloropropane (DBCP), a nematocide used on crops such as bananas and pineapple. Exposure of men to DBCP during manufacture or appli cation caused severe impairment of spermatogenesis and resulting infertility in a high proportion of highly exposed men. Other occupational exposures that have been shown in epidemiological studies to negatively affect spermatogenesis and/or sperm counts in men include inorganic lead and other heavy metals (cadmium, mercury arsenic), metal welding fumes and carbon disulphide. However, overall, the present view is that there is no firm evidence that exposure of adult men to common ECs, whether persistent or not, has any major impact on their fertility or semen quality although further studies of perfluorinated chemicals (alachlor, atrazine and diazinon) are warranted.
Precocious Male Puberty and Testotoxicosis
Testotoxicosis is a form of gonadotropinindependent precocious puberty in which boys experience early onset and progression of puberty. Patients have accele rated growth, early development of secondary sexual characteristics and usually reduced adult height. Testotoxicosis is caused by an activating mutation of the LHR, leading to increased levels of sex steroids in the context of low LH. Therapy has, therefore, traditionally targeted steroidogenesis. However, the drugs used have been associated with side effects. More recently, a combination of an oral antiandrogen spironolactone and an aromatase inhibitor testolactone decreased height velocity and improved predicted height. A phase II study in testotoxicosis is currently underway, explo ring the combination of a highly selective anti androgen, bicalutamide, and the potent aromatase inhibitor, anastrozole. These agents are well tolerated in the populations in which they have been studied and effec tively inhibit testosterone activity and estrogen production, in adult patients.
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Male Infertility
About 15% couples worldwide are childless due to infertility. Sixtyone countries are facing fertility related problems at or below the replacement level. Fifty percent of such infertility is because of the male factor and of which half is idiopathic in nature. 1 The cornerstone of diagnosis for males is the routine semen analysis in which sperm concentration, motility, morphology and the presence of other cells (spermatogenic and white blood cells) are assessed, as well as indicators of the patency and function of the genital tract (volume, liquefaction time, pH and fructose presence or absence) ( Table 3) .
The semen analysis, however, is not a test of fertility poten tial and indicates infertility only in the case of azoospermia (absence of sperm in the ejaculate; non obstructive and obstructive). The majority of endo crine disorders are relatively simple to diagnose and treat because of the availability of tests to diagnose endocrine defects. However, it is important to note that in patients suffering from such male infertility, hormonal therapy fails to initiate spermatogenesis. 6 In past decade, several mouse models have identified hundreds of proven candidate male infertility associated genes. 1, 4, 5 Due to lack of a rigorous clinical evaluation, these etiologies are not diagnosed properly. Therefore, it is high time to study the biology of the individual cells present inside the seminiferous epithelium.
New Advancements and Approaches to treat Male Infertility
Male GC Transplantation
In 1994, GC transplantation was developed by Dr Ralph Brinster et al at the University of Pennsylvania. These groundbreaking studies demonstrated that micro injection of GC from fertile donor mice into the seminiferous tubules of infertile recipient mice results in donor derived spermatogenesis and sperm production by the recipient animal. The use of donor males carrying the bacterial βgalactosidase gene allowed identification of donorderived spermatogenesis and transmission of the donor haplotype to the offspring by recipient animals. Surprisingly, after transplantation into the lumen of the seminiferous tubules, transplanted GC were able to move from the luminal compartment to the basement membrane where undifferentiated spermatogonia are located. It is generally accepted that only spermatogonial stem cells (SSCs) are able to colonize the niche and reestablish spermatogenesis in the recipient testis.
Therefore, GC transplantation provides a functional approach to study the stem cell niche of the testis and to characterize putative SSC. To date, GC transplantation is used to elucidate basic stem cell biology, to produce trans genic animals through genetic manipulation of GC prior to transplantation, to study SCGC interaction, SSC homing and colonization as well as SSC selfrenewal and differentiation. 6 
Xenotransplantation of Testicular Tissue
In 2002, Dobrinski et al demonstrated that small frag ments of testis tissue from immature males transplanted under the dorsal skin of immunodeficient mice are able to survive and undergo full development with the pro duction of fertilization competent sperm. Since, then testicular tissue xenografting has been shown to be suc cessful in many other species and emerged as a valuable alternative (other than GC transplantation) approach to understand testis development and spermatogenesis of larger animals including human in mice.
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In vitro Generation of Sperm Capable of Fertilization
Studies on in vitro spermatogenesis date back to organ culture experiments about a century ago. In 1937, it was reported that spermatogenesis proceeded up to the pachytene stage of meiosis in testis tissues of newborn mouse placed on a clot. In the 1960s, organ culture methods had advanced and various conditions were exten sively examined. However, it was not possible to promote spermatogenesis beyond the pachytene stage. Thereafter, cell culture methods, instead of organ culture, were used with new concepts and devices, including immortalized GC lines, the production of SC lines as feeder cells, bicameral chamber methods, etc. Despite of such endeavors, it has not been impossible to produce fertilityproven haploid cells from spermatogonial stem cells in vitro. In 2011, Takehiko Ogawa et al in Yokohama University, Japan have demonstrated that neonatal mouse testes which contain only gonocytes or undiffe rentiated spermatogonia as the only representative GC can pro duce spermatids and sperm in vitro with serumfree culture media. Spermatogenesis was maintained over 2 months in tissue fragments positioned at the gasliquid interphase. The obtained spermatids and sperm resulted in healthy and reproductively competent offspring through microinsemination. In addition, neonatal testis tissues were cryopreserved and, after thawing, showed complete spermatogenesis in vitro. This organ culture method developed by the team has been shown to be applicable through further refinements to a variety of Excessively high sperm concentration mammalian species, which will serve as a platform for future clinical application as well as mechanistic under standing of spermatogenesis. Moreover, this group has further developed a new in vitro system that can induce full spermatogenesis from SSC lines or any isolated SSC. This method depends on an organ culture system onto which SSC are transplanted. The settled SSC form colonies and differentiate up into sperm. The resultant haploid cells are fertile, and give rise to healthy offspring through microinsemination. Thus, these two in vitro cul ture systems are unambiguously the major advancement in the field of sperm biotechnology in the past 70 years of research and potentially create a strong hope for the upcoming challenge of human infertility. 8 
Functional Genomics and Differential Gene Expression
Researchers have initiated evaluating the status of genes expressed during spermatogenically active and inactive conditions of the testis by using differential genomics like differential display to high throughput cDNA microarray and next generation sequencing. Additionally, in vivo mouse models are being generated using transgenic or knock out/down technologies for such candidate genes to explore its functionality further as described in details by us before.
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FINAL CONCLUDING REMARKS
Genetic, physiological and lifestyle factors are known to affect male fertility. Male infertility and declining sperm count may pose a major challenge for human race. However, use of modern tools to undertake cellular and molecular analyses of such situation and studies of functional genomics to determine candidate genes respon sible for a particular phenotype may potentially help in understanding causes of such disabilities and remedies thereof. Gene therapy and stem cellbased therapy, though in infancy, may also contribute in future to reconstitute lost fertilizing potential of the males suffe ring from idiopathic infertility.
